Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Ginseng as a Complementary and Alternative Medicine for Postmenopausal Symptoms

  • Shim, Myeong-Kuk (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University) ;
  • Lee, Young-Joo (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Ginseng is a popular herbal medicine that has been used for thousands of years. A number of its components have been isolated and characterized, including ginsenosides, polysaccharides, peptides, polyacetylenic alcohols, and fatty acids. The lipophilic characteristics of ginsenosides have raised the possibility of their efficacy as steroid hormones. Several in-vitro studies have reported their pharmacological function as steroid hormones, especially estrogen, but no human study to date has confirmed their efficacy as alternatives to synthetic estrogen.

Keywords

References

  1. Joo HK, Lee SK, Kim HS, Song YJ, Kang O, Park JB, Lee KH, Cho EJ, Lee JR, Seong IW, Kim SH, Cho CH, Jeon BH. Korean red ginseng extract inhibits tumor necrosis factor-alpha-induced monocyte adhesion in the humanendothelial cells. J Ginseng Res. 3: 244-249 (2008)
  2. Lee JH, Choi SH, Nah sv Studyon life span extension efficacy by korean red ginseng. J Ginseng Res. 4: 210-216 (2007)
  3. Saiki Ikuo. In vivo anti-metastatic action of Ginseng Saponins is based on their intestinal bacterial metabolites after oral administration. J Ginseng Res. 1: 1-13 (2007)
  4. Attele AS, Wu JA, Yuan CS. Ginseng Pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693 (1999) https://doi.org/10.1016/S0006-2952(99)00212-9
  5. Yuan CS, Wu JA. Ginsenoside variability in American ginseng samples. Am J. Clin. Nut. 75: 600-601 (2002) https://doi.org/10.1093/ajcn/75.3.600
  6. Xing YZ, ShangHC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modem pharmacological experiment and clinical trials. Phytother Res. 22: 851-858 (2008) https://doi.org/10.1002/ptr.2384
  7. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann. Intern. Med. 137: 805-813 (2002) https://doi.org/10.7326/0003-4819-137-10-200211190-00009
  8. Hoffman GE, Zup SP. Good versus evil: changing the approach to hormone replacement therapy. Endocrinology. 144: 468-4699 (2003)
  9. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science. 304: 1269-1273 (2004) https://doi.org/10.1126/science.1096725
  10. Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, Haines CJ, Chan TY, Li M, Sham A. Comparison of Puerarialobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause. 10: 352-361 (2003) https://doi.org/10.1097/01.GME.0000054764.94658.33
  11. Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 288: 321-333 (2002) https://doi.org/10.1001/jama.288.3.321
  12. Lee YJ, Gorski J. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc Natl Acad Sci USA. 93: 15180-15184 (1996) https://doi.org/10.1073/pnas.93.26.15180
  13. Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta. Med. 69: 589-599 (2003) https://doi.org/10.1055/s-2003-41122
  14. Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int J .Vitam. Nutr. Res. 73: 120-126 (2003) https://doi.org/10.1024/0300-9831.73.2.120
  15. Yoon M, Lee H, Jeong S, Kim J.J., Nicol CJ. Nam KW, Kim M, Cho Bo, Oh Gr. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng. Brl. Pharmacol. 138: 1295-1302 (2003) https://doi.org/10.1038/sj.bjp.0705169
  16. Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, YooYB, Ko YC, Jun WT, Park HJ. Possible role of ginsenoside RbI on regulation of rat liver triglycerides. Biol. Pharm. Bull. 25: 457-460 (2002) https://doi.org/10.1248/bpb.25.457
  17. Nemmani KV, Ramarao P. Ginsenoside Rf potentiates U50,488H-induced analgesia and inhibits tolerance to its analgesia in mice. Life Sci. 72: 759-768 (2003) https://doi.org/10.1016/S0024-3205(02)02333-0
  18. Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides $Rb_1$ and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol. 134: 1159-1165 (2001) https://doi.org/10.1038/sj.bjp.0704377
  19. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol. Physiol. 23: 728-732 (1996) https://doi.org/10.1111/j.1440-1681.1996.tb01767.x
  20. Ernst E, Cassileth BR.How usefulare unconventional cancer treatments? Eur J. Cancer. 35: 1608-1613 (1999) https://doi.org/10.1016/S0959-8049(99)00198-7
  21. Choi S, Jung SY, Ko YS, Koh SR, Rhim H, Nah sv Functional expression of a novel ginsenoside Rf binding protein from rat brainmRNAin Xenopus laevis oocytes. Mol. Pharmacal. 61: 928-935 (2002) https://doi.org/10.1124/mol.61.4.928
  22. Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause. 9: 145-150(2002) https://doi.org/10.1097/00042192-200203000-00010
  23. Duda RB, Zhong YZ, Navas V, Li MZC, Toy BR. Alavarez JG. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J. Surg. Oncol. 72: 230-239 (1999) https://doi.org/10.1002/(SICI)1096-9098(199912)72:4<230::AID-JSO9>3.0.CO;2-2
  24. Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogenlikeactivity of ginsenoside Rgl derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 87: 3691-3695 (2002) https://doi.org/10.1210/jc.87.8.3691
  25. Lau WS, Chen WF, Chan RY, Guo DA, Wong MS. Mitoenactivated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rgl in human breast cancer(MCF-7) cells. Brl. Pharmacol. 156: 1136-1146 (2009) https://doi.org/10.1111/j.1476-5381.2009.00123.x
  26. Lee Y, Jin Y,Lim W, Ji S, Choi S, Jang S, Lee S. A ginsenoside-Rhl, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J. Steroid. Biochem. Mol. Biol, 84: 463-468 (2003) https://doi.org/10.1016/S0960-0760(03)00067-0
  27. FarhatMY, LavigneMC, Ramwell PW. The vascularprotective effects of estrogen. FASEB. J. 10: 615-624 (1996) https://doi.org/10.1096/fasebj.10.5.8621060
  28. Kim HS, Zhang YR, Fang LH, Lee MK. Effects of ginsenosides on bovine adrenal tyrosine hydroxylase. J. Ethnopharmacal. 66: 107-111 (1999) https://doi.org/10.1016/S0378-8741(98)00238-4
  29. Ivanova T, Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 54, 638-647 (2003) https://doi.org/10.1002/neu.10193
  30. MishraSI, Dickerson V, Najm W. Phytoestrogens and breast cancer prevention: what is the evidence? Am J. Obstet. Gynecol. 188: 66-70 (2003) https://doi.org/10.1067/mob.2003.405
  31. GlazierMG, BowmanMA. A reviewof the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med. 161: 1161-1172 (2001) https://doi.org/10.1001/archinte.161.9.1161
  32. Warnecke G Influencing menopausal symptoms with a phytotherapeutic agent: successful therapy withcirnicifuga monoextract. Med. Welt. 36: 871-874 (1985)
  33. Stoll W. Phytopharmacon influences atrophic vaginal epithetlium: double-blind study: cimicifuga versus estrogenic substances. Therapeutikon. 1: 23-31 (1987)
  34. E Lehrnann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl. Gynakol. 110: 611-618 (1988)
  35. Jacobson JS, Troxel AS, Evans J. Randomized trial of black cohoshfor the treatment of hot flashes amongwomenwith a history of breastcancer. J. Clin. Oncol. 19:2739-2745 (2001) https://doi.org/10.1200/JCO.2001.19.10.2739
  36. Liske E, Wtistenberg P. Therapy of climacteric complaints with Cimicfuga racemosa: a herbal medicine with clinically provenevidence. Poster Presentation. North American Menopause Society (1998)
  37. Liske E, Hanggi W, Henneicke-von ZepelinHH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a uniqueextract of black cohosh (Cimicifugae racemosae rhizoma): a six-month clinical study demonstrates no systemic estrogenic effect. J. Womens Health Gend Based. Med. 11: 163-174 (2002) https://doi.org/10.1089/152460902753645308
  38. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 versusconjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 44: S67-S77 (2003) https://doi.org/10.1016/S0378-5122(02)00350-X
  39. Viereck V, Emons G, Wuttke W. Black cohosh: just another phytoestrogen? Trends. Endocrinol. Metab. 16: 214-221 (2005) https://doi.org/10.1016/j.tem.2005.05.002
  40. Davis VL,Jayo MJ, Ho A, Kotlarczyk MP, HardyM.L, Foster WG, Hughes CL. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2. Cancer. Res. 68: 8377-83 (2008) https://doi.org/10.1158/0008-5472.CAN-08-1812
  41. Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. : Gynecol. Endocrinol. 25: 166-74 (2009) https://doi.org/10.1080/09513590802549866
  42. Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extracton quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group.: Int J. Clin. Pharmacol. Res. 19: 89-99 (1999)
  43. Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on psychological functions in patients with severeclimacteric syndromes. Int J. Gynaecol. Obstet. 67: 169-74 (1999) https://doi.org/10.1016/S0020-7292(99)00168-X
  44. Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch. Intern. Med. 166: 1453-65 (2006) https://doi.org/10.1001/archinte.166.14.1453
  45. Hartley DE,Elsabagh S, File SE. Gincosan (a combination of Ginkgobiloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr. Neurosci. 7: 325-33 (2004) https://doi.org/10.1080/10284150400015557